Image Rotator

Over 300 clinical trials are available right now at Sanford Health. Learn more.
Today’s best treatments were yesterday’s clinical trials
Over 300 clinical trials are available right now at Sanford Health. Learn more.

There are currently no Featured Stories.


Sanford Research is a non-profit research organization that is a part of Sanford Health, the largest rural, not-for-profit health care system in the nation. Transformational gifts by Denny Sanford have propelled Sanford Research in its goal of becoming a world class research institution. Sanford Research has sought to establish a core of scientists that are studying disease at a fundamental level with the expectation that these current efforts will pay off in the future by advancing disease therapy and prevention.

 

With a team of over 200 researchers, Sanford Research is comprised of eight groups that bridge bench, translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population Health.

  • Oncology group chooses Sanford for first clinical trial

    Sanford launches national TAPUR Study for patients with advanced cancer. The clinical study offers FDA-approved, molecularly targeted drugs to participants.

    Learn More

  • Sanford launches innovative data project to improve patient care

    Dakota universities part of effort

    Learn More

  • New clinical trial launches at Sanford

    Head and neck cancer patients could benefit from new checkpoint inhibitor treatment at Sanford.

    Learn More

  • Sanford Enrolling Patients for Head, Neck Cancer Trial

    Studying investigational drug to determine if it helps activate immune system

    Learn More

Twitter Updates on Sanford Research
  • @SanfordStacy
    RT @SanfordHealth: “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https:…

  • @SanfordCoRDS
    RT @NIH: Tune in tomorrow at 5:20pmET for a Facebook Live w/ @BillGates & @NIHDirector on global health&genetics https://t.co/bJXPeRCHzo #A…

  • @DrAllisonW
    RT @SanfordHealth: “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https:…

  • @DrDavidPearce
    RT @SanfordHealth: “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https:…

  • @runnerJPK
    “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https://t.co/bewA1oFZ8V

  • @Sanford_Palfy
    “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https://t.co/FAE5G26KA6

  • @SanfordHealth
    “We aim to truly legitimize the use of adult-derived stem cells for healing purposes in the U.S.” @DrDavidPearce https://t.co/RReb8sJ0Hf

  • @Elvys09
    RT @AtypicalHUS: Happy to be part of this! https://t.co/CSuYI0Mkse

  • @AtypicalHUS
    Happy to be part of this! https://t.co/CSuYI0Mkse

  • @DrDavidPearce
    RT @SanfordCoRDS: That's right! Our #raredisease #patient #database has nearly 700 diseases represented and over 4250 participants from 55…

  • @SanfordCoRDS
    That's right! Our #raredisease #patient #database has nearly 700 diseases represented and over 4250 participants fr… https://t.co/im2G7ZgnAO

  • @runnerJPK
    @scienmag This is awesome. @SanfordHealth and @SanfordResearch do a ton with rare disease and our @SanfordCoRDS database.

  • @DrDavidPearce
    RT @SanfordHealth: Rare disease is just one thing @DrDavidPearce talks about with @PLalleyShow in this clip. Another topic? Soccer. https…

  • @SanfordHealth
    Rare disease is just one thing @DrDavidPearce talks about with @PLalleyShow in this clip. Another topic? Soccer. https://t.co/KUD4GL6TP9

  • @Sanford_Palfy
    Rare disease is just one thing @DrDavidPearce talks about with @PLalleyShow in this clip. Another topic? Soccer. https://t.co/LcGiWaKtbn